Atrial Fibrillation Trial, Recruiting NCT07174206 Sponsor: University of Sao Paulo Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07174206
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with a heart or blood vessel (cardiovascular) condition, are male or female, and are older than 22 years of age
  • You are willing and able to sign a consent form agreeing to take part in the study
  • You agree to follow the study's procedures and requirements throughout the trial
  • You are either being monitored as an outpatient for a cardiovascular condition, or your doctors have recommended a procedure such as a heart valve replacement, a procedure to treat an irregular heartbeat, or a procedure to open blocked heart arteries
  • You have little or no risk of skin damage, based on a standard assessment tool or your care team's evaluation

Who may not be able to join:

  • You have a skin condition such as vitiligo, lupus, or eczema (atopic dermatitis), or have tattoos on your wrist that could interfere with the smartwatch's sensor readings
  • You have a known allergy or sensitivity to materials used in wearable devices, such as adhesives or electrode pads
  • You are unable to use wearable monitoring devices due to physical, thinking/memory, or technology-related difficulties
  • You have a type of medical line inserted into a vein (PICC line) or a surgically created connection between an artery and vein in your arm (arteriovenous fistula)
  • You have an implanted heart device such as a pacemaker, defibrillator, or cardiac resynchronization device that would prevent a smartwatch from recording a heart tracing (ECG)
  • You have been diagnosed with a condition that causes narrowing or blockage of certain major arteries (such as certain types of aortic dissection, Takayasu arteritis, Subclavian Steal Syndrome, or Kawasaki disease), which could affect blood pressure readings between your arms (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +551126615462

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 February 2025
Est. completion
31 January 2026

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Incidence and number of Atrial Fibrillation (AF) events detected; Number of critical health alerts generated by the FAPO-SI³ platform; Patient risk classification generated by the AI model

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov